Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology: Pilot Study
| Registry | NCT03453788, acronym LETSGO |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; non randomized, parallel, masking: none, supportive care |
| Enrollment | 24 (Actual) |
| Sponsor | Sorlandet Hospital HF (Other gov); collaborators: University of Agder, Uppsala University |
| Conditions | Gynecologic Cancer |
| Interventions | LETSGO app (Device) |
| Dates | start 2018-03-20, primary completion 2019-05-31, completion 2019-05-31, first posted 2018-03-05, last updated 2019-09-12 |
| Locations | 1 site in Norway |
Related Papers Related Patents Related Grants Related Experts
All trials for Gynecologic Cancer All trials of LETSGO app
This pilot study is evaluating a new smartphone application named the LETSGO app. The LETSGO app is designed to promote empowerment in patients after treatment for gynecological cancer.
Gynecological cancer treatment is increasingly successful, resulting in a rising number of cancer survivors. Many gynecological cancer survivors may experience late side effects from their cancer treatment. In addition, evidence is accumulating that an active lifestyle may increase empowerment and may positively influence well-being after cancer treatment. Through the LETSGO smartphone app, women treated for gynecological cancer will get access to individualized posttreatment information on side effects as well as tailored physical activity advices in order to assume more responsibility for achieving the best outcomes from her care. The participants will also regularly answer patient reported outcomes regarding possible recurrence though the app. As a first step the smart-phone application will be pilot-tested.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Intervention group | Experimental | Device: LETSGO app | Alternating follow-up visits by nurse and doctor. In the nurse-led consultations, the patients will be introduced to the smartphone LETSGOapp with access to information on cancer treatment and side effects, physical activity advice. Two-monthly assessment of 12 symptoms that may represent relapse through the app.The patients will fill in an electronic questionnaire package at baseline, 3, and 6 months after treatment. |
| Reference group | No intervention | Regular hospital follow-up.The patients will fill in an electronic questionnaire package at baseline, 3, and 6 months after treatment. |
Sex: Female, ages: 18 Years to any
Inclusion Criteria: * Patients diagnosed and treated for gynecological cancer who will be followed up at the gynecological outpatient clinic in Kristiansand or Arendal * No cognitive barriers. Exclusion Criteria: * < 18 years * Not able to read Norwegian
| Facility | City | Country | Status |
|---|---|---|---|
| Sorlandet Hospital | Kristiansand, Vest Agder | Norway |